Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:20:53 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:IRIX - IRIDEX CORP - https://www.iridex.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
IRIX - Q0.11.29·5.004.01.46+0.032.130.2353281.48  1.5099  1.431.6485  0.78219:30:03Feb 0215 min RT 2¢

Recent Trades - Last 10 of 328
Time ETExPriceChangeVolume
19:30:03Q1.46830.038310
16:10:04Q1.460.031
16:00:02Q1.460.033,606
16:00:02Q1.460.031
16:00:02Q1.460.031
16:00:02Q1.460.031
16:00:02Q1.460.031
16:00:02Q1.460.033
16:00:02Q1.460.031
15:59:13Q1.480.052

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-02 07:00U:IRIXNews ReleaseIridex Announces Plans to Relocate Headquarters
2026-01-12 07:00U:IRIXNews ReleaseIridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
2025-12-11 07:00U:IRIXNews ReleaseIridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse(TM) Technology in Glaucoma Management
2025-12-08 07:00U:IRIXNews ReleaseIridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse(TM) Technology and Continuous-Wave Laser for Glaucoma Treatment
2025-12-05 07:00U:IRIXNews ReleaseIridex to Present at the Sidoti Year-End Virtual Investor Conference
2025-11-11 16:05U:IRIXNews ReleaseIridex Reports Third Quarter 2025 Financial Results
2025-10-28 16:05U:IRIXNews ReleaseIridex to Report Third Quarter 2025 Financial Results on November 11, 2025
2025-09-09 16:05U:IRIXNews ReleaseIridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
2025-08-12 16:05U:IRIXNews ReleaseIridex Reports Second Quarter 2025 Financial Results
2025-07-29 16:05U:IRIXNews ReleaseIridex to Report Second Quarter 2025 Financial Results on August 12, 2025
2025-06-24 07:00U:IRIXNews ReleaseIridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse(TM) Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
2025-05-13 16:05U:IRIXNews ReleaseIridex Reports First Quarter 2025 Financial Results
2025-04-30 16:05U:IRIXNews ReleaseIridex to Report First Quarter 2025 Financial Results on May 13, 2025
2025-04-14 16:05U:IRIXNews ReleaseIridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
2025-04-09 16:05U:IRIXNews ReleaseIridex to Host Strategic Vision Call on April 16, 2025
2025-03-27 16:05U:IRIXNews ReleaseIridex Reports Fourth Quarter and Full Year 2024 Financial Results
2025-03-19 09:15U:IRIXNews ReleaseIridex Announces Strategic Investment in the Company
2025-03-14 07:00U:IRIXNews ReleaseIridex Comments on Recent Stock Price Volatility
2025-03-13 17:00U:IRIXNews ReleaseIridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025